With nothing else to do but wait, I looked up the backgrounds of the two rapporteurs assigned to Anavex. Vrijlandt is from the Netherlands, Wang is from Norway. Links to their CV’s are below:
There’s also a small thumbnail about Vrijlandt’s background. Note the reference to his interest in gender differences in the safety of medicinal products. Seems I recall Anavex’s focus on this subject.